Duration of botulinum toxin efficacy in cervical dystonia clinical trials: A scoping review
Authors:
Open Access
- 29 May 2024
- journal article
- review article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 125, 107011
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Assessing the Severity of Cervical Dystonia: Ask the Doctor or Ask the Patient?Movement Disorders Clinical Practice, 2023
- Isolated Cervical Dystonia: Diagnosis and ClassificationMovement Disorders, 2023
- Conversion to AbobotulinumtoxinA Increases Waning Time and Efficacy for Cervical DystoniaMovement Disorders Clinical Practice, 2023
- The Prevalence of Idiopathic or Inherited Isolated Dystonia: A Systematic Review and Meta‐AnalysisMovement Disorders Clinical Practice, 2022
- LIVECHART Patient‐Reported Outcome Tool for Botulinum Toxin Treatment in Cervical DystoniaMovement Disorders Clinical Practice, 2022
- Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized‐controlled trialMovement Disorders, 2016
- Botulinum toxin type B vs. type A in toxin‐naïve patients with cervical dystonia: Randomized, double‐blind, noninferiority trialMovement Disorders, 2007
- Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystoniaMovement Disorders, 2006
- Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double‐blind, placebo‐controlled studyMovement Disorders, 2005
- A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystoniaJournal of Neurology, 2002